Topics

High-grade gliomas | Treatment | Radiotherapy | Re-irradiation

Home > Publications > Topics > High-grade gliomas > Treatment > Radiotherapy > Re-irradiation

Saad E, Abdelwahed M, Moussa R, Abdulla M.
Comparison between Reirradiation by Stereotactic Body Radiation Therapy and Moderately Hypofractionated Radiotherapy in Combination with Temozolomide for Treatment of Recurrent High Grade Glioma.
Asian Pac J Cancer Prev. 2024 Jul 19;25(7):2499-2507. doi: 10.31557/APJCP.2024.25.7.2499. PMID: 39068585. Observational study. ˍ

González ML, Ciervide R, Requejo OH, Luis ÁM, Rodriguez BÁ, Saugar ES, Iracheta LA, Chen X, Garcia-Aranda M, Zucca D, Valero J, Alonso R, Fernández- Letón P, Rubio C.
Reirradiation of gliomas with hypofractionated stereotactic radiotherapy: efficacy and tolerance analysis at a single center.
Rep Pract Oncol Radiother. 2024 Oct 15;29(5):566-578. doi: 10.5603/rpor.102820. PMID: 39759563. Observational study. ˍ

Sahebjam S, Raval RR, Forsyth PA, Enderling H, Tran ND, Arrington JA, Macaulay R, Perlow HK, Palmer JD, Ghose J, Rajappa P, Giglio P, Li Z, Etame AB, Mokhtari S, Cruz-Chamorro RJ, Bhandari M, Thapa R, Robinson TJ, Chen DT, Yu HM.
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas.
Neurooncol Adv. 2025 Feb 8;7(1):vdaf033. doi: 10.1093/noajnl/vdaf033. PMID: 40134851. Interventional study. ˍ